May 14 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2019 Mar 31, 2018 Mar 31, 2020 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 35.84 32.31 36.00 17.13
(+10.9 pct) (+10.0 pct) (+0.4 pct) (-1.4 pct)
Operating 5.46 3.56 6.20 2.92
(+53.7 pct) (+11.0 pct) (+13.5 pct) (+11.2 pct)
Recurring 5.67 3.86 6.45 3.00
(+46.7 pct) (+7.9 pct) (+13.9 pct) (+12.4 pct)
Net
Net 3.66 2.34 4.25 1.95
(+56.6 pct) (+72.6 pct) (+16.2 pct) (+13.3 pct)
EPS 30.38 yen 19.39 yen 35.29 yen 16.20 yen
Ann Div 7.00 yen 4.50 yen 8.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 7.00 yen 4.50 yen 8.00 yen
NOTE - Takara Bio Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T